Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

SELL
$256.56 - $292.34 $2.57 Million - $2.92 Million
-10,000 Reduced 20.0%
40,000 $11.1 Million
Q4 2022

Feb 13, 2023

BUY
$252.44 - $306.72 $12.6 Million - $15.3 Million
50,000 New
50,000 $13.8 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Senator Investment Group LP Portfolio

Follow Senator Investment Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Senator Investment Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Senator Investment Group LP with notifications on news.